Preclinical |
Anthelminthic/Vaccine |
UDP-glucuronosyltransferase (UGT) |
Detoxifies molecules Saeed et al., 2018
|
|
|
Enolase |
Binds to plasminogen and assists in invading host tissue Jiang et al., 2019
|
|
|
Endocannabinoid (eCB) |
Regulates parasite metabolism and development Batugedara et al., 2018; Ma et al., 2019b
|
|
|
Dafachronic acid (DA) |
|
|
|
Serpin |
Inhibits host blood coagulation Yi et al., 2010
|
|
|
α-Gal |
Induces host production of protective antibodies Hodžić et al., 2020
|
|
Clinical |
|
Hemoglobinase aspartic protease (APR-1) |
Involved in the hemoglobin detoxification pathway Hotez et al., 2013
|
|
|
Glutathione S-transferase (GST-1) |
|
|
|
Ancylostoma secreted protein-2 (ASP-2) |
Although effective in animal models, caused generalized urticaria in clinical trial Diemert et al., 2012
|
|
Preclinical |
Anti-Inflammatory |
Anti-inflammatory protein-2 (AIP) |
Promotes Tregs to suppress airway inflammation Navarro et al., 2016
|
|
|
Alarmin release inhibitor (ARI) |
Binds to IL-33 and inhibits its release Osbourn et al., 2017
|
|
|
Binds ARI (BARI) |
Binds to receptor for IL-33 Vacca et al., 2020
|
|
|
Glutamate dehydrogenase (GDH) |
Induces anti-inflammatory eicosanoid switch de Los Reyes et al., 2020
|
|
|
Cystatin |
Reduces inflammatory cytokines and promotes Tregs Hartmann et al., 2002
|
|
|
Macrophage inhibitory factor (MIF) |
Suppresses the immune system through structures homologous to host cytokines Johnston et al., 2017; Cho et al., 2011
|
|
|
TGF-β mimic (TGM) |
|
|
|
p43 |
Binds and inhibits IL-13 Bancroft et al., 2019
|
|
|
ES-62 |
Interacts with a broad range of immune cells to downregulate an inflammatory response Suckling et al., 2018
|
|
|
DNase |
Impairs worm killing by degrading neutrophil extracellular traps Bouchery et al., 2020
|
|
|
Extracellular vesicles (EVs) |
Disrupt immune cell function and contain miRNAs Eichenberger et al., 2018
|